Wellington Management Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106M | Sell |
5,232,326
-3,121,825
| -37% | -$63.5M | 0.02% | 506 |
|
|
2025
Q1 | $152M | Sell |
8,354,151
-621,682
| -7% | -$11.3M | 0.03% | 417 |
|
|
2024
Q4 | $227M | Sell |
8,975,833
-267,766
| -3% | -$6.77M | 0.04% | 340 |
|
|
2024
Q3 | $314M | Buy |
9,243,599
+1,167,659
| +14% | +$39.7M | 0.06% | 293 |
|
|
2024
Q2 | $299M | Buy |
8,075,940
+428,483
| +6% | +$15.9M | 0.05% | 299 |
|
|
2024
Q1 | $321M | Buy |
7,647,457
+1,170,896
| +18% | +$49.1M | 0.06% | 307 |
|
|
2023
Q4 | $257M | Buy |
6,476,561
+1,044,728
| +19% | +$41.4M | 0.05% | 346 |
|
|
2023
Q3 | $149M | Buy |
5,431,833
+300,406
| +6% | +$8.27M | 0.03% | 437 |
|
|
2023
Q2 | $174M | Buy |
5,131,427
+949,816
| +23% | +$32.2M | 0.03% | 424 |
|
|
2023
Q1 | $150M | Sell |
4,181,611
-466,301
| -10% | -$16.8M | 0.03% | 451 |
|
|
2022
Q4 | $207M | Buy |
4,647,912
+1,567,179
| +51% | +$69.8M | 0.04% | 379 |
|
|
2022
Q3 | $86.6M | Buy |
3,080,733
+240,350
| +8% | +$6.76M | 0.02% | 555 |
|
|
2022
Q2 | $76.6M | Sell |
2,840,383
-689,457
| -20% | -$18.6M | 0.02% | 594 |
|
|
2022
Q1 | $120M | Buy |
3,529,840
+1,343,864
| +61% | +$45.8M | 0.02% | 550 |
|
|
2021
Q4 | $84.5M | Buy |
2,185,976
+5,624
| +0.3% | +$217K | 0.01% | 674 |
|
|
2021
Q3 | $118M | Buy |
2,180,352
+217,353
| +11% | +$11.7M | 0.02% | 581 |
|
|
2021
Q2 | $65.6M | Buy |
1,962,999
+74,263
| +4% | +$2.48M | 0.01% | 741 |
|
|
2021
Q1 | $38.9M | Buy |
1,888,736
+1,794,536
| +1,905% | +$37M | 0.01% | 884 |
|
|
2020
Q4 | $1.65M | Buy |
+94,200
| New | +$1.65M | ﹤0.01% | 1518 |
|
|
2014
Q2 | – | Sell |
-668
| Closed | -$177K | – | 2159 |
|
|
2014
Q1 | $177K | Buy |
+668
| New | +$177K | ﹤0.01% | 2117 |
|
|
2013
Q3 | – | Sell |
-107,872
| Closed | -$25.3M | – | 2176 |
|
|
2013
Q2 | $25.3M | Buy |
+107,872
| New | +$25.3M | 0.01% | 893 |
|